Association between Lipid Profile and Ovarian Cancer in women of North India

Sunita Tiwari, Arti Verma, Pushplata Sankhwar, Anila Dwivedi, Rohit Kumar Srivastava, Dinesh Tripathi, Pratibha Singh


Objective: The aim of this study is to compare serum lipid profiles: total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c) and very low density lipoprotein cholesterol (VLDL-c) and lipid ratio among ovarian cancer patients and healthy controls.

Methods: Total 300 subjects were enrolled in this study. Study group comprised of 150 clinically and histologically proved cases of ovarian carcinoma and 150 healthy women recruited as a control group. Plasma levels of   TC, TG, LDL-cholesterol and HDL-cholesterol, VLDL and the ratio of lipid profile were estimated by using semi-autoanalyzer.  

Results: In our study, we found the higher level of mean serum cholesterol, TGs, LDL-c and VLDL in ovarian cancer patients as compared to the controls. The HDL level is higher in controls as compared to study group. TGs, HDL-c VLDL were found highly significant in OC patients as compared to controls. The Ratio of TC/HDL, LDL/HDL, HDL/LDL was also found significantly higher in OC patients as compared to controls.

Conclusions: The results of the present study show that plasma lipid levels, except HDL-cholesterol, are increase in OC. As there is an alteration in the plasma lipid profile during gynecologic cancers, it may be helpful for diagnosis of the disease. Further studies to group important factors including, cancer stages and type of cancer, parity, and menopausal status that may affect lipid profiles in OC patients along with an investigation of new lipid profiles to clarify most lipid factors that may involve in OC development are needed.


Ovarian cancer, lipid profiles, lipoproteins, serum lipids, lipids ratio

Full Text:



Landis SH, Murray T and Bolden S: Cancer statistics. CA Cancer J Clin 1999; 8: 49-54.

Fathalla MF. Incessant ovulation—A factor in ovarian neoplasia? Lancet 1971; 2 (7716):163.

Huang R, Lin Y, Flowers L, Lisoukov H, Wang Q, Shi Q, Horowitz I R, Parthasarathy S, Huang R P. Molecular Profiling of Circulating Cytokine Levels in Human Ovarian Cancer Patients. Cancer genomics & proteomics 2004; 1: 23-32.

R. T. Greenlee, T. Murray, S. Bolden, and P. A. Wingo, “Cancer statistics, 2000,” Ca-A Cancer Journal for Clinicians, 2000; vol. 50, 1, 7–33.

Ruochun Huang, Ying lin, Lisa Flowers, Henry Lisoukov, Qian Wang, Qian shi, Ira R. Horowitz, Sampath Parthasarathy, Ruo-Pan Huang: Molecular Profiling of Circulating Cytokine Levels in Human Ovarian Cancer Patients Cancer Genomics & Proteomics,2004; 1: 23-32 .

Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011, 144(5):646–674.

Xiao, Y, Chen, Y, Kennedy, A.W, Belinson, J, Xu, Y. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann. N. Y. Acad. Sci. 2000, 905, 242–259.

Xu, Y, Shen, Z, Wiper, D.W, Wu, M., Morton, R.E.; Elson, P.; Kennedy, A.W.; Belinson, J.;Markman, M.; Casey, G. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998, 280, 719–723.

Nelson DL, Cox MM. Bioenergetics and metabolism. In: Lehninger AL, Nelson DL, Cox MM, eds. Lehninger Principles of Biochemistry. 3rd ed. New York: Worth Publishers; 2000: 598–619,770–814.

Granados S, Quiles JL, Gil A, Ramírez–Tortosa MC. Dietary lipids and cancer [Spanish]. Nutr Hosp 2006;21:42–52.

Patel PS, Shah MH, Jha FP, Raval GN, Rawal RM, Patel MM, et al. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer. 2004;41:25–31.

Singh S, Ramesh V, Premalatha B, Prashad KV, Ramadoss K (2013). Alteration in serum lipid profile patterns in oral cancer. J Nat Sci Biol Med, 4, 374-8.

Tania, M.; Khan, M.A.; Song, Y. Association of lipid metabolism with ovarian cancer. Curr. Oncol. 2010, 17, 6–11.

Carmen E. P, Fuller M , Ricciardelli C , Oehler MK . Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer Int. J. Mol. Sci. 2013, 14, 7742-7756.

Naik PP, Ghadge MS, Raste AS. Lipid profile in leukemia and Hodgkin’s disease. Indian J Clin Biochem, 2006; 21, 100-2.

Raste AS, Naik PP. Clinical significance of lipid; profile in cancer patients. Indian J Med Sci, 2000; 54, 435-41.

Mehrotra R, Pandya S, Chaudhary AK, et al . Lipid profile in oral submucous fibrosis. Lipids Health Dis, 2009; 8, 29.

Gupta RK, Patel AK, Kumari R, et al. Interactions between oxidative stress, lipid profile and antioxidants in breast cancer: a case control study. Asian Pac J Cancer Prev, 2012; 13, 6295-8.

Laisupasin P, Thompat W, Sukarayodhin S, Somprom A, Sudjaroen Y . Comparison of serum lipid profiles between normal controls and breast cancer patients. J Lab Physicians,2013; 5, 38-41.

Kalyani R, Shruthi SP, Narayanaswamy M, Sumathi M E, Chandramouli A, Lee J K. Significance of the Plasma Lipid Profile in Cases of Carcinoma of Cervix: A Tertiary Hospital Based Study. APJCP.2014;15.8.3779.

Chawda JG, Jain SS, Patel HR, Chaduvula N, Patel K . The relationship between serum lipid levels and the risk of oral cancer. Indian J Med Paediatr Oncol, 2011; 32, 34-7.

Ozdemir BH, Akeali Z, Haberal M. Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and therefore lowers the risk of metastases. Am J Clin Pathol,2004; 122, 696-703.

Hasija K, Bagga HK. Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Indian Journal of Clinical Biochemistry. 2005; 20: 61-66.

Nayak P, Nayak S, Darafsh MD (2010). Alteration in plasma lipid profile in precancerous conditions. J Nepal Dent Asso, 11, 40-5.


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


  • There are currently no refbacks.

Copyright (c) 2015 International Journal of Biomedical Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.